Sixty Degrees Pharmaceuticals
Pre-clinical60° Pharmaceuticals (60P)—a specialty pharmaceutical corporation dedicated to leading the way in the development and commercialization of infectious disease medicines for COVID-19, malaria, dengue and other infectious diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $10.9M
About
60° Pharmaceuticals (60P)—a specialty pharmaceutical corporation dedicated to leading the way in the development and commercialization of infectious disease medicines for COVID-19, malaria, dengue and other infectious diseases.
Small Molecules
Funding History
3Total raised:$10.9M
Debt$2.5MJun 15, 2020
Grant$3.4MJun 15, 2017
Series A$5MJun 15, 2015